Contattaci
Circa la società
Lux Biosciences, Inc., a biotechnology company, develops medications to treat ophthalmic diseases. Its products include LX201, a silicone matrix ocular implant that enables the release of cyclosporine A to the eye for one year; Luveniq, an oral form of calcineurin inhibitor voclosporin; LX212, a bioerodible polymer implant that contains voclosporin; and LX214, a topical mixed nanomicellar formulation of voclosporin therapy for dry eyes. The company was founded in 2005 and is based in Jersey City, New Jersey.
US
Sconosciuto
Azienda non verificata
Trasparenza aziendale
- Informazioni sull'azienda non verificate
- Chiedi ai loro clienti per le recensioni
- Non ha risposto alle recensioni negative